Boardroom Alpha
Research library
SPACs · Jul 13, 2026

SPAC Market Update July 13, 2026: PLMK Cuts Merger Value, RACD Prices $75M IPO

Plum Acquisition Corp IV (PLMK) amended its merger agreement on July 13, 2026, lowering earnouts and merger value and extending key deadlines. Separately, Research Alliance Corp IV (RACD) priced a $75M SPAC IPO on July 13, 2026.

SPAC IPO Update — July 13, 2026

1 SPAC IPO priced on July 13, 2026, raising $75M; July MTD now stands at 7 IPOs totaling $1.60B over 13 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 7Prior: 21MoM: -14
13
Jul ’25
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
21
Jun ’26
7
Jul ’26
Source: Boardroom Alpha
IPO Activity Snapshot1 SPAC IPO today raising $75M · RACD ($75M)
Month-to-date: 7 IPOs ($1.60B) vs. first 13 days of last month 12 ($2.29B) · 12-mo avg: 17/mo
$ totals include underwriter over-allotment.
Size
$75M
Ticker

Research Alliance Corp IV filed for a $75M IPO on July 13, 2026, with plans to list on an unspecified exchange. No specific target sector disclosed.

Leadership
Alan A MussoDirector
Alan Musso is the CFO of Fulcrum Therapeutics, previously served as CFO at ReViral Ltd., Peloton Therapeutics, and Bellicum Pharmaceuticals.
Fran AdamsCFO
Fran Adams is a Partner at van den Boom and Associates, with over 20 years in accounting and finance, serving as CFO for various private life sciences companies.
John Michael MaslowskiDirector
John Maslowski is the President and CEO of Forge Biologics, previously held executive roles at Castle Creek Biosciences and Fibrocell Science.
Matthew HammondCEO, Director
Matthew Hammond is a Partner at RA Capital Management, former CFO of Research Alliance Corp. I, and has served on several biotech company boards.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Jul 13 RACD Research Alliance Corp IV $75M 100.0%
Jul 10 SAMO Samos Energy Acquisition Corp $200M 100.0%
Jul 08 FDMM Freedom Metals Acquisition Corp. $275M 100.0%
Jul 07 BCCQ BLEICHROEDER ACQUISITION CORP III $300M  $45M overallotment 100.0%
Source: Boardroom Alpha

Daily SPAC Update — July 13, 2026

SPAC EXTENSIONS
FUTURE VISION II ACQUISITION CORP (FVN) * Extension FilingSponsor provides a $191,475 extension promissory note to extend the business combination deadline to Aug 13, 2026. The note is convertible into units at $10 per unit upon a successful business combination and may be forgiven if no deal; the company continues pursuing a MicroTouch merger, but no guarantee of completion by the extended date.
EUREKA ACQUISITION CORP (EURK) * Extension FilingEureka Acquisition extends the business combination deadline to Aug 3, 2026, via a funded extension and related note.

SPAC DEAL TERMINATIONS (Last 10 Days)
2026-07-07: AFJK + United Hydrogen Group Inc.

SEPARATE WARRANTS/RIGHTS
July 14: BURTECH ACQUISITION CORP II (BRKH)
July 13: TEXAS VENTURES ACQUISITION IV CORP (TVIV)
July 13: YORKVILLE INTERNATIONAL CAPITAL CORP (YICC)

OTHER SPAC NEWS
PLUM ACQUISITION CORP IV (PLMK) * Merger Agreement AmendmentSecond amendment to the business combination lowers earnouts and merger value, and extends key deadlines.
RF ACQUISITION CORP III (RFAM) * Merger Agreement

SPAC DEALS ANNOUNCED
July 9 | Rf Acquisition Corp III (RFAM) + HCC Healthcare Pte. Ltd.HCC Healthcare Pte. Ltd. operates one of the largest integrated platforms for medical and long-term care services in Taiwan. Its offerings include hospitals, clinics, pharmacies, rehabilitation, hemodialysis, caregiver support, and community- and home-based care. The company manages over 120 long-term care facilities and more than 9,000 beds, and it is exploring growth opportunities in AI-enabled care, the Japanese market, wellness partnerships, and precision and regenerative medicine.

SPAC Executive & Director Moves — July 13, 2026

SPAC Executive & Director Moves
Company Ticker Moves
COLUMBUS CIRCLE CAPITAL CORP III CCCTU
  • On July 9, 2026, Garrett Curran, Alberto Alsina Gonzalez, Matthew Murphy, and Marc Spiegel were appointed as independent directors of the Company’s Board, with various committee assignments.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — July 13, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RISING DRAGON ACQUISITION CORP RDAC 11.1% $ 6.00 Announced
STONEBRIDGE ACQUISITION II CORP APAC 5.2% $ 14.16 Pre-Deal
EUREKA ACQUISITION CORP EURK 2.8% $ 12.44 Announced
RESEARCH ALLIANCE CORP III RACC 2.8% $ 11.00 Pre-Deal
GP-ACT III ACQUISITION CORP GPAT 2.2% $ 11.11 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
LEAPFROG ACQUISITION CORP LFAC -35.2% $ 10.03 Pre-Deal
FUTURE VISION II ACQUISITION CORP FVN -7.5% $ 11.00 Announced
CHURCHILL CAPITAL CORP XI CCXI -4.2% $ 15.55 Announced
BEST SPAC I ACQUISITION CORP BSAA -2.9% $ 11.99 Announced
FG MERGER II CORP FGMC -2.3% $ 9.81 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What changed in PLMK‘s merger agreement amendment?
    Plum Acquisition Corp IV (PLMK) lowered earnouts and merger value and extended key deadlines under a second amendment to its business combination agreement.
  • How many SPAC IPOs priced in July 2026 through July 13?
    7 SPAC IPOs priced for $1.60B through July 13, 2026, compared with 12 IPOs for $2.29B over the same first 13 days of June 2026.
  • How large was Research Alliance Corp IV’s IPO?
    Research Alliance Corp IV (RACD) priced a $75M SPAC IPO on July 13, 2026. The issuer lists Matthew Hammond as CEO and director, Fran Adams as CFO, and Alan Musso as a director.
  • Which SPACs extended deadlines via sponsor funding?
    Future Vision II Acquisition Corp (FVN) extended its deadline to Aug. 13, 2026 via a sponsor note, and Eureka Acquisition Corp (EURK) extended its deadline to Aug. 3, 2026 via a funded extension.
  • What is RFAM‘s merger target?
    RF Acquisition Corp III (RFAM) has a merger agreement with HCC Healthcare Pte. Ltd., a Taiwan healthcare and long-term-care services platform.


ShareXLinkedIn

Published Jul 13, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer